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Oxidative stress-related phenotypic changes and a decline in the number of viable cells are crucial contributors to intervertebral
disc degeneration. The polyphenol epigallocatechin 3-gallate (EGCG) can interfere with painful disc degeneration by reducing
inflammation, catabolism, and pain. In this study, we hypothesized that EGCG furthermore protects against senescence and/or cell
death, induced by oxidative stress. Sublethal and lethal oxidative stress were induced in primary human intervertebral disc cells with
H
2
O
2
(total 𝑛 = 36). Under sublethal conditions, the effects of EGCGonp53-p21 activation, proliferative capacity, and accumulation
of senescence-associated𝛽-galactosidasewere tested. Further, the effects of EGCGonmitochondria depolarization and cell viability
were analyzed in lethal oxidative stress. The inhibitor LY249002 was applied to investigate the PI3K/Akt pathway. EGCG inhibited
accumulation of senescence-associated 𝛽-galactosidase but did not affect the loss of proliferative capacity, suggesting that EGCG
did not fully neutralize exogenous radicals. Furthermore, EGCG increased the survival of IVD cells in lethal oxidative stress via
activation of prosurvival PI3K/Akt and protection of mitochondria. We demonstrated that EGCG not only inhibits inflammation
but also can enhance the survival of disc cells in oxidative stress, which makes it a suitable candidate for the development of novel
therapies targeting disc degeneration.
1. Introduction
Degenerative disc disease, characterized by spinal microin-
stability and lower back pain, is a result of multiple events
like age-related degradation of extracellular matrix (ECM),
inflammation, or trauma [1, 2]. During degeneration, the
intervertebral disc (IVD) undergoes morphological and
functional changes such as calcification of endplates, disrup-
tion of annulus fibrosus (AF), and loss of water in the nucleus
pulposus (NP), which not only impairs disc function but also
decreases nutrient supply and causes accumulation of cellular
waste products [3–5]. In such situation, cells can compensate
for impaired homeostasis, for example, by activation of neo-
vascularization factors, to enhance the availability of nutri-
ents. However, a catabolic environment and abnormal blood
supply in the originally avascular tissue can increase reactive
oxygen species (ROS) production and oxidative stress [6–10].
ROS are highly reactive molecules with unpaired elec-
trons formed externally or in mitochondria as a normal part
of the aerobic metabolism. To ensure a properly maintained
redox balance, organisms require a complex, coordinated
network of antioxidants from various sources that control
ROS generation [11]. Cellular responses to ROS depend on
their concentration and duration of exposure as well as the
cell type. As signaling molecules, ROS modulate a variety of
physiological events, including proliferation, differentiation,
host defense, and wound healing [12]. On the other hand,
extensive ROS exposure and/or insufficient cellular antioxi-
dant capacity cause deleterious damage, senescence, and cell
death [13].
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Cellular senescence is described as an irreversible stress-
induced cell cycle arrest [14]. Senescence followed by tissue
remodeling is beneficial in healthy tissue, where it contributes
to the elimination of damaged cells. Furthermore, it is amajor
protective mechanism against carcinogenesis. However, at
the same time, persistent senescence impairs tissue function
and leads to inflammation and premature degeneration [15].
Internal DNA damage (telomere shortening) as well as
multiple stress signals, including ROS, aberrant oncogene
activation, and chemotherapeutic drugs, are able to induce
premature senescence via activation of the p53-p21 and/or p16
Ink4a pathway [16]. Although cell and tissue aging has been
extensively investigated, the precise mechanisms underlying
the development of a senescence phenotype are still unknown
[14].
Extensive oxidative stress disrupts the integrity of mito-
chondria, which can further elicit cell death through three
major mechanisms. During apoptosis (1), cytochrome c is
released into the cytosol where it activates caspase-9, which
allows executioner caspases 3, 6, and 7 to cleave their
substrates [17]. Caspase-independent cell death mechanisms,
such as regulated necrosis (2) or autophagy (3), are equally
important in various pathologies, including IVD degenera-
tion [18, 19]. Similar to senescence, the biological purpose
of apoptosis is to eliminate damaged or suboptimal cells
[15], although both processes are regulated differently [14].
During apoptosis, a variety of triggers can quickly converge
to the executioner effectors through a common mechanism.
In contrast, senescence is typically a delayed progressive
process, during which various effector mechanisms can each
contribute and collectively define the phenotype [14].
The functionality of human IVDs as spinal shock-
absorbers gradually decreases throughout lifetime. Senes-
cence of IVD cells, which positively correlates not only
with age, but also with the degree of disc degeneration, can
be linked to oxidative stress [10, 20–27]. Oxidative stress-
induced senescence and death of IVD cells contribute to
the local tissue inflammation and the expression of matrix
degrading enzymes, hence accelerating loss of proteoglycans
[28]. Extensive production of mitochondrial ROS during
IVD cell death may further impair disc tissue homeosta-
sis [6, 19, 29–31]. Apart from oxidative stress, also other
factors, like nonphysiological mechanical loading, an acidic
environment, or autoimmune reactions, can alter the cellular
phenotype and enhance premature senescence and cell death
in the IVD [25, 32, 33].
Despite the fact that IVD degeneration and back pain
represent an economic burden, only symptomatic therapies,
like analgesics or invasive surgeries, are currently available.
Such therapies do not target the biological causes of disc
degeneration and either offer only temporary relief or entail
risks and complications. The focus of the current research
is to restore the disc function via prevention of premature
aging, inhibition of cell death, and enhancement of ECM
maintenance with an ultimate goal to prevent low back pain
[4, 34]. One approach to compensate the loss of functional
disc cells is to apply stem cells embedded in diverse bio-
materials mimicking disc tissue, which may support the old
disc population and “rejuvenate” the aging disc. However,
the implanted cells can in some cases undergo incorrect dif-
ferentiation, can induce inflammatory reactions, andmay not
survive due to a prior catabolic environment [35, 36]. Another
approach is to enhance survival of the existing intrinsic disc
cells using various pharmacological agents such as growth
factors or inhibitors of inflammatory pathways [4, 37].
We have previously shown that epigallocatechin 3-gallate
(EGCG), a polyphenol naturally occurring in green tea,
inhibits inflammatory responses in IVD cells in vitro and
exhibits analgesic activity against disc-related radiculopathy
in experimental animals [38]. The aim of this in vitro
study was to (1) further investigate whether EGCG exhibits
protective effects in mild and high oxidative stress and to (2)
investigate the molecular mechanism involved.
2. Methods
2.1. DPPH Radical Scavenging Activity Assay. Antioxidant
activity of EGCG was determined by measuring its scaveng-
ing capacity of the 2,2󸀠-diphenyl-1-picrylhydrazyl (DPPH)
radical as previously described [39]. 100 𝜇L of 10–300𝜇M
EGCG was incubated with 500𝜇L of DPPH (250 𝜇M in
ethanol; D9132 Sigma, Buchs, Switzerland) for 1 hour at room
temperature (𝑛 = 3).DPPHradical scavenging activity, which
manifests itself as a decrease in absorbance, was measured
at 517 nm with a spectrophotometer (Infinite M200 PRO,
TECAN Group AG, Ma¨nnedorf, Switzerland). L-Ascorbic
acid (A4403, Sigma) and ethanol (02860, Sigma) in equal
amounts were used as positive and negative control, respec-
tively. DPPH radical scavenging activity (%) was calculated
as [negative control optical density (OD) − sample OD] ∗
100/negative control OD.
2.2. Cell Isolation and Cell Culture. The study was approved
by the cantonal ethic committee (Kantonale Ethikkom-
mission Zu¨rich EK-16/2005). After informed consent was
granted, human NP tissue (grades III–V) was removed from
donors undergoing spinal surgeries for degenerative disc
disease or disc herniation (𝑛 = 36). Details about the
donors for this study are listed in Table 1. The tissue was
enzymatically digested using a mixture of 0.2% collagenase
NB4 (17454, Serva, Heidelberg, Germany) and 0.3% dispase
II (04942078001, Roche, Basel, Switzerland) for 4–8 hours at
37∘C and isolated primary cells were seeded in Dulbecco’s
Modified Eagle’s Medium (DMEM/F12, D8437, Sigma, St.
Louis, MO, USA), supplemented with 10% fetal calf serum
(FCS, F7524, Sigma), penicillin (50 units/mL), streptomycin
(50 𝜇g/mL), and ampicillin (125 ng/mL, 15240-062, Gibco,
Carlsbad, CA, USA) and subcultured up to passage 3 using
1.5% trypsin (15090-046, Gibco). Adherent cells in passages
1–3 were used for experiments. Due to the small biopsy
size, low proliferation rate, and dedifferentiation of primary
IVD cells in monolayer, a single donor cannot be used for
all required experiments. Therefore, different donors were
randomly assigned to the specific experiments. Cells were
seeded on 6-well plates at a density of 1 × 105 cells per well
for all senescence experiments. Cells were seeded on 12-well
plates at a density of 1× 105 cells perwell for all lethal oxidative
stress experiments, except JC-1 staining assay, which was
Oxidative Medicine and Cellular Longevity 3
Table 1: Intervertebral disc pathologies used for primary cell cultures.
Donor information Experiments
Number Gender, age Levelpathology, grade Sublethal oxidative stress Lethal oxidative stress
1 M, 35 L4/L5Herniation IV
H
2
O
2
sensitivity study, p21 time course
Senescence validation
10 days: additive effect
H
2
O
2
sensitivity study
PI/A
2 F, 77 L4/L5DDD III
p21 time course
10 days: additive effect JC-1, MTT
3 F, 53 L4/L5DDD IV
H
2
O
2
sensitivity study, p21 time course
Senescence validation
10 days: additive effect
H
2
O
2
sensitivity study
PI/A, MTT
4 F, 39 L5/S1Herniation V
H
2
O
2
sensitivity study
Senescence validation
10 days: antioxidant
H
2
O
2
sensitivity study
PI/A, MTT
5 F, 31 L4/L5Herniation uk
H
2
O
2
sensitivity study
Senescence validation
H
2
O
2
sensitivity study
JC-1, PI/A, MTT
6 F, 64 L4/L5DDD III
H
2
O
2
sensitivity study
Senescence validation
H
2
O
2
sensitivity study
JC-1, PI/A, MTT
7 F, 53 L5/S1Herniation IV — JC-1
8 M, 50 L4/5DDD III — JC-1
9 F, 54 L5/S1Herniation V 10 days: recovery, RT qPCR —
10 M, 64 L5/S1Herniation III 10 days: recovery, RT qPCR —
11 M, 44 L5/S1Her IV 10 days: antioxidant, RT qPCR —
12 M, 56 L4/L5Herniation III 10 days: recovery, RT qPCR —
13 F, 51 C4/5Herniation III 10 days: antioxidant —
14 F, 42 L3/L4Herniation III 10 days: antioxidant —
15 F, 35 L5/S1DDD, Herniation IV 10 days: recovery —
16 M, 41 L4/L5DDD III 10 days: additive effect —
17 M, 40 L5/S2DDD, Herniation V 10 days: antioxidant —
18 M, 50 L4/L5DDD, Herniation III 10 days: additive effect —
19 F, 42 L3/L4Herniation III 10 days: recovery —
20 M, 43 L5/S1DDD, uk — JC-1, bright field, MTT, MTT (I)
21 F, 51 L4/L5DDD IV — JC-1, bright field, MTT, MTT (LY), MTT (I)
22 M, 47 L4/L5DDD, Herniation III — JC-1, bright field, MTT
23 F, 44 L4/L5DDD III — JC-1, bright field, MTT, MTT (LY), MTT (I)
24 F, 43 L5/S1DDD, Herniation III — JC-1, bright field, MTT, MTT (LY), MTT (I)
25 M, 47 L4/5DDD, Herniation III — Lethal: MTT (LY), MTT (I)
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Table 1: Continued.
Donor information Experiments
Number Gender, age Levelpathology, grade Sublethal oxidative stress Lethal oxidative stress
26 M, 39 L4/5DDD, Herniation IV — Lethal: MTT (LY), MTT (I)
27 M, 21 L5/S1Herniation III — Lethal: MTT (LY), MTT (I)
28 F, 43 L4/5DDD, Herniation IV — Lethal: MTT (LY), MTT (I)
29 M, 33 L5/S1Herniation III — Lethal: WB
30 F, 39 L5/S1DDD, Herniation III — Lethal: MTT (LY), WB, MTT (I)
31 F, 39 L4/5DDD, Herniation IV — Lethal: MTT (LY), WB, MTT (I)
32 uk uk — Lethal: MTT (LY), WB
33 M, 55 L3/4DDD III — Lethal: WB
34 F, 56 L3/4Herniation IV — Lethal: MTT (LY), WB
35 M, uk L4/5Herniation uk — Lethal: MTT (LY)
36 uk uk — Lethal: MTT (LY)
DDD: degenerative disc disease, PI/A: Propidium Iodide/Annexin staining, MTT: MTT assay, MTT (LY): MTT assay with LY, MTT (I): MTT assay with
insulin, and uk: unknown.
Table 2: Experimental design.
Sublethal oxidative stress, induction of premature senescence
Experimental setup Stress phase (2 hours) Recovery phase (up to 15 days) Tested EGCG effect
(1) Antioxidant 50 𝜇MH
2
O
2
+ 10𝜇M EGCG — ROS neutralization
(2) Recovery 50 𝜇MH
2
O
2
+10𝜇M EGCG Interaction with poststress signaling(e.g., changes in gene expression)
(3) Combined 50𝜇MH
2
O
2
+ 5 𝜇M EGCG +5𝜇M EGCG ROS neutralizationInteraction with poststress signaling
Lethal oxidative stress, cell death induction
Experimental setup Stress phase (24 hours) Tested EGCG effect
(1) Survival 100 and 200 𝜇MH
2
O
2
+ 10𝜇M EGCG ProsurvivalAntioxidant
performed on 6-well plates. After seeding, cells were left to
adhere overnight.
2.3. Experimental Design and Treatments. Oxidative stress
was induced with H
2
O
2
(V800211, Sigma), which initiates
the generation of ROS that are able to attack all types of
biomolecules [40, 41]. The active concentration of H
2
O
2
was
selected based on the results of a preliminaryH
2
O
2
sensitivity
study (𝑛 = 5). Increasing concentrations of H
2
O
2
(10–
200𝜇M) were applied for 24 hours and cellular responses
were tested by MTT assay. The lethal concentration of H
2
O
2
(100 𝜇M and 200𝜇M for 24 hours) as well as the sublethal
concentration of H
2
O
2
which can induce senescent changes
without significant cell death (50𝜇M H
2
O
2
applied for 2
hours, followed by recovery period) were identified. FCS-free
media were used during all oxidative stress treatments to rule
out the possible interaction of radicals with FCS components.
Previously reported nontoxic EGCG concentrations (5𝜇M
and 10 𝜇M) were applied in this study [38].
The effect of EGCG (E4143, Sigma) on premature senes-
cence was tested in three different experimental setups to
identify mechanism of EGCG’s action (Table 2): (1) to test its
antioxidant activity, 10 𝜇M EGCG was applied in the stress
phase simultaneously with H
2
O
2
, (2) to test its effects on
poststress processes, 10 𝜇M EGCG was added only in the
recovery phase, and (3) to combine its potential benefits in
both phases, 5 𝜇M EGCG was added in the stress phase and
later again in the recovery phase.
The effect of 10𝜇MEGCGon cell deathwas tested directly
in the stress phase, without recovery period (Table 2). To
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further test the involved mechanism, LY294002, an inhibitor
of the PI3K/protein kinase B (Akt) pathway (LY, L9908,
Sigma), was applied at a concentration of 10 𝜇M, along
with EGCG (𝑛 = 10). PI3K/Akt activator insulin (I9278,
Sigma) was used at a concentration of 0.5𝜇L/mL to confirm
functionality and specificity of LY in our experiments (𝑛 =
10).
2.4. In Vitro Model System of Premature Senescence. Prema-
ture senescencewas inducedwith sublethalH
2
O
2
. After seed-
ing, cells were starved in FCS-free medium for 2 hours before
applying 50 𝜇M H
2
O
2
for another 2 hours. As a next step,
media were replaced by completemedia (+10% FCS) to let the
cells recover from oxidative stress. Premature senescence was
monitored for 15 days with media exchange on days 5 and 10.
To verify senescence-associated changes, various tests were
performed: senescence-associated 𝛽-galactosidase activity
was tested on days 1, 5, 10, and 15 after stress (𝑛 = 5). The
number of viable cells was determined by Trypan blue exclu-
sion test on days 8 and 15 (𝑛 = 5). Cellular metabolic activity
was measured by MTT assay and expression/activity of
senescence-associated proteins p21 and p53 was analyzed by
immunoblotting on day 15 (𝑛 = 5). In a separate experiment
on day 8, trypsin-detached cells were reseeded again to check
their ability to adhere, which reflects general cellular fitness.
2.5. Senescence-Associated SA 𝛽-galactosidase Assay. Senes-
cence-associated 𝛽-galactosidase (SA 𝛽-gal), which accumu-
lates in aging cells, serves as a reliable marker of senescence
in vitro [42]. Senescence was induced with 50𝜇MH
2
O
2
, fol-
lowed byEGCG treatments as described above (𝑛 = 5 for each
experimental setup). For SA 𝛽-gal analysis, staining solution
containing 40mM Na
3
citrate × 2H
2
O + 5mM K
4
Fe(CN)
6
+ 5mM K
3
Fe(CN)
6
+ 0.15M NaCl + 2mM MgCl
2
in H
2
O
was prepared and its pH was adjusted to 6 by adding 0.5M
NaH
2
PO
4
(all from Sigma). X-gal (11680293, Roche) was
dissolved in dimethylformamide (33120, Sigma) to prepare a
20mg/mL stock solution. Adherent cells were washed twice
with PBS and fixed with 3% paraformaldehyde (30525894,
Acros, Geel, Belgium) in PBS for 5 minutes at room temper-
ature. After the fixation, cells were washed twice with PBS
and a mixture of X-gal + staining solution in a 1 : 20 ratio
was added. After 18 hours, the staining solution was removed
and cells were washed two times in distilled water and passed
through graded ethanol (75%, 95%, 99%), 1 minute each.
After air-drying, micrographs were taken from 3 random
spots of each well using light microscopy. The number of all
cells (minimum 300) and SA 𝛽-gal positive cells was counted
by processing images with GIMP (http://www.gimp.org/)
and ImageJ (http://imagej.nih.gov/ij/). The percentage of SA
𝛽-gal positive cells in each treatment group was calculated
as the number of SA 𝛽-gal positive cells/number of all cells
∗ 100. SA 𝛽-gal positive cells in the treatment groups were
displayed relative to the control groups, due to the high
interdonor variability in basal SA 𝛽-gal staining.
2.6. Trypan Blue Exclusion Test. Trypan blue staining, which
distinguishes viable and dying cells, was performed to
analyze the total number of viable cells at the end of each
experiment. Senescence was induced with 50𝜇M H
2
O
2
and
EGCG treatments were performed as described above (𝑛 =
5 for each experimental setup). Cells were harvested using
1.5% trypsin into the complete media, an aliquot was mixed
1 : 1 with 0.4% Trypan blue dye (93595, Fluka), and the cell
suspension was immediately analyzed on the grids of the
hemacytometer (DHC-N01,Thermo Scientific).The absolute
number of nonstained (viable) cells was determined in each
group to make a comparison with the total number of seeded
cells (1 × 105 cells per well). Nonviable cells, which took up
Trypan blue dye, were excluded from the analysis.
2.7. Metabolic Activity Measurement. Metabolic activity,
which reflects cellular viability, was determined using the
MTT assay. Following seeding, sublethal or lethal oxidative
stress was applied and the treatments were performed as
described above (𝑛 = 5 for sublethal oxidative stress exper-
iments, 𝑛 = 10 for lethal oxidative stress experiment, and
𝑛 = 10 for inhibition experiments). After 24 hours or 10 days,
fresh MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetra-
zolium bromide,M5655, Sigma) solution in PBS (0.5mg/mL)
was added and kept for 3 hours at 37∘C. MTT was discarded,
cells were lysed inDMSO (D8418, Sigma), and the absorbance
was measured at 565 nm. Metabolic activity was calculated
relative to the untreated control (100%).
2.8. Immunoblotting. Treatments were performed as
described above. Cells were harvested after 15min treatment
for lethal oxidative stress experiments (𝑛 = 5) or after 10
days and 15 days for sublethal oxidative stress experiments
(𝑛 = 5). Whole cell lysates were prepared in RIPA buffer
(89900, Thermo Scientific, Waltham, MA, USA) according
to the producer’s instructions, mixed with Laemmli buffer
(S3401, Sigma), heated (99∘C, 5 minutes), and then loaded
onto 12% SDS polyacrylamide gels. Separated proteins
were transferred onto polyvinylidene difluoride (PVDF)
membranes (RPN303F, GE Healthcare, Little Chalfont,
UK) and membranes were blocked in 5% nonfat milk in
Tris-buffered saline-Tween (TBS-T) for 1 hour at room
temperature. Primary antibodies were applied overnight at
4∘C. After washing in 1% nonfat milk in TBS-T (3 × 10min),
membranes were incubated with a secondary antibody
conjugated to horseradish peroxidase (HRP) for 1 hour at
room temperature and washed in 1% nonfat milk in TBS-T
(3 × 10min). Visualization was performed on medical X-ray
film (28906836, GE Healthcare), using a chemiluminescence
kit West Dura (34076, Thermo Scientific). Tubulin was used
as a loading control. Antibodies and dilutions were as follows:
phospho-p53 (Ser15) 1 : 1000 (9284, Cell Signaling, Danvers,
MA, USA); p21 1 : 1000 (2947, Cell Signaling); phospho-Akt
(Ser473) 1 : 1000 (9271, Cell Signaling); Akt 1 : 1000 (9272, Cell
Signaling); p16 Ink4a (p16) 1 : 1000 (ab108349, Abcam); 𝛼-
Tubulin 1 : 1000 (2144, Cell Signaling); and mouse anti-rabbit
IgG HRP 1 : 5000 (7074, Cell Signaling).
2.9. Analysis of Mitochondrial Transmembrane Potential (JC-1
Staining). JC-1 fluorochrome (5,5󸀠,6,6󸀠-tetrachloro-1,1󸀠,3,3󸀠-
tetraethylbenzimidazolcarbocyanine iodide) allows for
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monitoring changes in mitochondrial transmembrane
potential, which precedes cell death. In physiological
conditions, JC-1 accumulates in the intact mitochondrial
membrane, where it forms pronounced red aggregates. Once
mitochondrial membrane potential is disturbed, the red
fluorescence decreases, which is accompanied by an increase
in green fluorescence of the free JC-1 form. A substantial
increase in the green fluorescence (= reduced red/green
ratio) suggests a breakdown of mitochondrial potential and
activation of cell death.
Lethal oxidative stress was applied and EGCG treat-
ment was performed as described above (𝑛 = 10). After
24 hours, 1 𝜇g/mL of JC-1 (T0046, Chemodex, St. Gallen,
Switzerland) diluted in FCS-free media was added to the
cells and kept at 37∘C in the dark for 30 minutes. Then,
cells were washed (3 × PBS) and images of 3 random
spots per well were taken immediately with a fluorescence
microscope (Olympus IX51, Volketswil, Switzerland). The
ratio of red/green fluorescence was calculated using ImageJ
analysis (http://imagej.nih.gov/ij/).
2.10. Propidium Iodide/Annexin V-FITC Staining. The mem-
brane of living cells is impermeable for Propidium Iodide
(PI), a red fluorescent dye which intercalates into DNA.
Annexin V-FITC (A) binds membrane phosphatidylserine,
which is exposed to the extracellular environment as one of
the early apoptotic events. Flow cytometry analysis of PI/A
staining allows distinguishing viable cells (PI-negative/A-
negative), cells in early apoptosis (PI-negative/A-positive),
and dead cells (PI-positive/A-positive) [43].
Lethal oxidative stress was applied and EGCG treatment
was performed as described above (𝑛 = 5). After 24 hours,
supernatants were collected into prechilled tubes and placed
on ice. Cells were washed with PBS, detached from cell
culture wells with 1.5% trypsin, and transferred into the
corresponding prechilled tubes with matching supernatants.
All the further steps were performed on ice. Cell-supernatant
mixtures were centrifuged (250×g/5min, 4∘C), supernatants
were discarded, and 400 𝜇L of Annexin Binding Buffer
(556454, BD Biosciences, Franklin Lakes, NJ, US) was added
to the pellets and mixed. After the addition of 1 𝜇L of PI
(556463, BDBiosciences) and 2.5 𝜇L of Annexin (556420, BD
Biosciences), tubes were kept in the dark for 15 minutes. Flow
cytometry was performed immediately using the cytometer
FACS ARIA III (BD Biosciences). Results were analyzed
with FlowJO (http://www.flowjo.com/) and are displayed as
percentage of viable cells (PI−/A−) in each treatment group.
Unstained cells, cells stained with Annexin V-FITC alone,
and cells stained with PI alone were used as controls to set
up quadrants.
2.11. Gene Expression Analysis (RT-qPCR). The effect of
sublethal oxidative stress on the activation of senescence-
associated secretory phenotype (SASP) was tested by means
of gene expression of interleukin-6 (IL-6), interleukin-
8 (IL-8), matrix metalloproteinase 1 (MMP1), matrix
metalloproteinase 3 (MMP3), and matrix metalloproteinase
13 (MMP13). These genes are typically expressed in
a proinflammatory and catabolic environment during
inflammation-related disc degeneration [44, 45]. IVD cells
were seeded on 6-well plates and senescence was induced
as described above (𝑛 = 4). After 24 hours, RNA was
extracted with the Trizol/chloroform method according
to the manufacturer’s instructions (15596-018, Invitrogen,
Carlsbad, CA, USA) and 1 𝜇g was reverse transcribed to
cDNA using a reverse transcription kit (4374966, Applied
Biosystems). cDNAwas then mixed with primers andmaster
mix (4352042, Applied Biosystems) and gene expression was
measured using real-time PCR. The following primers were
used: TATA box binding protein (TBP) Hs00427620 m1,
IL-6 Hs00174131 m1, IL-8 Hs00174103 m1, MMP1
Hs00233958 m1, MMP3 Hs00968308 m1, and MMP13
Hs00233992 m1. Data was analyzed with the comparative Cq
method (2−ΔΔCq, housekeeping gene TBP). Results are pre-
sented as a fold change relative to the untreated control group.
2.12. Statistical Analysis. A power calculation (80% power)
determined the required sample size (𝑛 = 5). Data normality
was tested by Schapiro-Wilk test. Statistical significance
between two groups was analyzed using Student’s 𝑡-test.
Statistical significance between more than two groups was
evaluated byANOVAwith Tukey post hoc test.The number of
donors used for each experiment is listed in Methods. Mean
and SEM are displayed in graphs and asterisks represent a
significance level of 𝑝 < 0.05.
3. Results
3.1. Validation of the In Vitro Model System of Premature
Senescence of IVD Cells. Based on the sensitivity study, 50
𝜇M H
2
O
2
applied for 2 hours and followed by a recovery
period up to 15 days was chosen to induce premature
senescence of IVD cells without significant cell death (Sup-
plementary Figure 1 in Supplementary Material available
online at http://dx.doi.org/10.1155/2016/7031397). Analysis of
senescence-associated changes was performed on days 1, 5,
8, 10, and 15 after stress. In the H
2
O
2
treatment group, the
number of SA𝛽-gal positive cells increased significantly from
day 1 (12.67 ± 2.05%) up to day 15 (49.53 ± 4.58%) after
stress, compared with the untreated controls (Figure 1(a)).
Representative images of SA 𝛽-gal staining on day 8 and
reseeded cells on day 9 are shown (Figure 1(b)). Reseeded
cells in the H
2
O
2
treatment group were able to adhere, which
confirmed a good general cellular fitness; however, altered
cellular morphology suggested an aging cell population.
Phosphorylation of the stress-induced protein p53 (Ser15)
and enhanced expression of the cell cycle inhibitor p21 on day
15 in the H
2
O
2
treatment group indicated oxidative damage
(Figure 1(c)). In order to compare the replicative potential of
stressed and control cells, the living cells were counted on
days 8 and 15 by Trypan blue exclusion test. The cell number
on day 8 in the H
2
O
2
group (1.53 ± 0.16 × 105 cells/well)
was significantly lower than in the control group (2.63 ±
0.18×10
5 cells/well), confirming oxidative stress-induced loss
of proliferative capacity. Cell death in the H
2
O
2
group on
day 8 did not occur, as the number of cells was higher than
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Figure 1: In vitromodel system of stress-induced premature senescence. Sublethal oxidative stress (50 𝜇MH
2
O
2
) with subsequent recovery
period activated premature senescence of IVD cells in vitro. (a) Percentage of SA 𝛽-gal-positive cells in the H
2
O
2
treatment group gradually
increased during 15 days after stress (𝑛 = 5). (b) Upper part: representative images of SA 𝛽-gal staining of the untreated (ctrl) and the H
2
O
2
-
treated cells on day 8 after stress, showing senescent (blue) cells. (b) Lower part: representative images of reseeded cells on day 9, confirming
general cellular fitness. (c) Phosphorylation of p53 (Ser15) and expression of p21 in the H
2
O
2
treatment group on day 15 after stress indicated
cellular senescence. ((d), (e)) Proliferative capacity, displayed as number of cells on days 8 and 15 after stress, was reduced in the H
2
O
2
groups.
On day 15, the number of cells in the H
2
O
2
treatment group decreased below the seeding number (1 × 105 cells per well, depicted as red line),
suggesting ongoing cell death. Asterisks indicate statistical significance at 𝑝 < 0.05 (ANOVA, Tukey post hoc, and Student’s 𝑡-test).
the cell seeding density on day 0 (1 × 105 cells/well, marked
as red line) (Figure 1(d)). However, on day 15, the number
of cells in the H
2
O
2
treatment group decreased below the
seeding density (0.68 ± 0.13 × 105 cells/well versus 1 ×
105 cells/well, marked as red line), indicating that the cells
slowly started to die from the ROS exposure (Figure 1(e)).
As cell death may hamper data interpretation, all subsequent
experiments were performed for a maximum of 10 days.
The expression of inflammatory genes in the H
2
O
2
treatment group, measured on day 1, was not significantly
elevated (Supplementary Figure 1).
3.2. EGCG Inhibited Senescence-Associated 𝛽-galactosidase
Accumulation in Sublethal Oxidative Stress. Previously
reported antioxidant properties of EGCG were confirmed
using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical assay.
EGCG exhibited a dose-dependent radical scavenging
activity between 10 and 100𝜇M. As a common antioxidant,
ascorbic acid at the same concentrations was used as a
positive control (Figure 2(a)) [46]. Apart from its antioxidant
effects, EGCG may also possess other beneficial functions.
Therefore, the effect of EGCG on the accumulation of SA
𝛽-gal was tested in 3 different experimental setups displayed
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Figure 2: As an antioxidant, EGCG inhibited senescence-associated 𝛽-galactosidase accumulation. (a) EGCG exhibited increasing 2,2-
diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity between 10 and 100𝜇M, which confirmed its antioxidant properties. Ascorbic
acid in the same concentration was used as positive control (𝑛 = 3). ((b)–(d)) Oxidative stress was induced with 50𝜇MH
2
O
2
for 2 hours and
cellular senescence was measured during the following 10 days. 10𝜇M EGCG inhibited SA 𝛽-gal accumulation when added to the oxidative
stress phase, when its antioxidant activity was confirmed (𝑛 = 5). (c) 10 𝜇M EGCG added to the recovery phase did not influence SA 𝛽-gal
accumulation compared to the H
2
O
2
-only group (𝑛 = 5). (d) EGCG combined in both phases (5 + 5 𝜇M) did not significantly inhibit SA
𝛽-gal accumulation, although a trend is visible (𝑛 = 5). Asterisks indicate statistical significance at 𝑝 < 0.05 (ANOVA, Tukey post hoc).
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in Table 2, namely, (1) antioxidant activity by adding EGCG
in the stress phase, (2) activity on poststress signaling by
adding EGCG in the recovery phase, and (3) potential
combined effect by adding EGCG in both phases.
The percentage of SA 𝛽-gal positive cells was evaluated
on days 1, 5, and 10 after stress. EGCG significantly inhibited
the accumulation of SA 𝛽-gal on days 5 and 10 when added
during the stress phase, indicating that an antioxidant mech-
anism is involved (Figure 2(b)). EGCG did not influence the
rate of SA 𝛽-gal accumulation during the recovery phase,
suggesting that the interaction of EGCG with poststress
signaling is less relevant (Figure 2(c)).The presence of EGCG
in both phases did not provide significant protection against
oxidative stress, which is most likely caused by insufficient
ROS neutralization, as lower concentrations of EGCG (5 𝜇M)
were used in the stress phase of this setup. However, an
apparent trend towards statistical significance was detectable
(Figure 2(d)).
3.3. EGCGDid Not Protect IVD Cells from Loss of Proliferative
Capacity in Sublethal Oxidative Stress. The effects of EGCG
on proliferation and expression of the senescence markers
p53 and p21 were also tested in each experimental setup:
(1) EGCG as an antioxidant, (2) EGCG in recovery, and
(3) combined effects. In order to compare the proliferative
capacity of H
2
O
2
-treated and H
2
O
2
+ EGCG-treated cell
populations, the number of viable cells on day 10 of recovery
period was determined in each treatment group. Untreated
and EGCG-treated cells proliferated, but all stress groups
showed significantly lower cell numbers, regardless of the
presence of EGCG (Figures 3(a)–3(c)). On day 10 after
stress, p53 was slightly phosphorylated in all stress groups.
Expression of p21 was induced by H
2
O
2
but also not affected
by the presence of EGCG, hence indicating that exogenous
ROS were not entirely neutralized by 10 𝜇M EGCG (Figures
3(d)–3(f)).
As both nonsenescent and senescent cells are metaboli-
cally active, detectedmetabolic activity on day 10 corresponds
to the number of cells in each treatment group: stress groups
showed significantly lower metabolic activity than untreated
controls. No significant difference between the H
2
O
2
and
H
2
O
2
+ EGCG treatment groups was detected in either
experimental setup, confirming that EGCG did not protect
IVD cells from loss of proliferative capacity (Figures 3(g)–
3(i)). Metabolic activity of cells on day 10 is displayed relative
to the control group (100%).
3.4. EGCG Protected IVD Cells from Lethal Oxidative Stress
via Inhibition of Mitochondrial Membrane Depolarization.
Based on the sensitivity study, 100𝜇M and 200𝜇M H
2
O
2
applied for 24 hours were identified to trigger significant
cell death (Supplementary Figure 1). As such ROS doses may
induce excessive mitochondria membrane depolarization
and unrepairable damage, the general prosurvival effect of
EGCG can be tested.
Extensive oxidative stress (100 𝜇M H
2
O
2
) significantly
decreased the metabolic activity of IVD cells (51.49 ±
5.64%), compared with the control group (100%), while
the addition of EGCG reversed this effect (80.58 ± 4.31%)
(Figure 4(a)). More specifically, PI/A staining confirmed
significantly higher number of living cells in the H
2
O
2
+
EGCG treatment group (52.91 ± 8.02%) compared to the
H
2
O
2
-only group (28.31 ± 5.83%) (Figure 4(b)).
During lethal oxidative stress, mitochondria lose their
transmembrane potential, which leads to the release of
mitochondrial ROS and serves as a proapoptotic signal.
EGCGmay possibly interact with ROS on the mitochondrial
membrane and prevent further ROS leakage. To test this
hypothesis, the JC-1 dye, which forms red aggregates in
intact mitochondria, was used. H
2
O
2
in a concentration
of 100 𝜇M (Figure 5(a)) and 200 𝜇M (Figure 5(b)) caused
extensive mitochondrial membrane depolarization, while
the addition of EGCG prevented this effect. The red/green
fluorescence ratio of the untreated (10.19 ± 4.54) and the
EGCG-treated (8.15±3.29) cells was significantly higher than
the ratio of both H
2
O
2
treatment groups (100𝜇M: 1.85 ±
0.96, 200𝜇M: 0.09 ± 0.07). Addition of EGCG significantly
increased the ratio in H
2
O
2
treatment groups to 6.05 ± 1.14
(100 𝜇M) and 0.63 ± 0.2 (200𝜇M) (Figure 5(d)). Membrane
blebbing and nuclear shrinkage were detected in the H
2
O
2
+
EGCG treatment group, confirming that the cells were not
completely protected from deleterious ROS and cell death
was possibly only delayed (Figure 5(c)).
3.5. EGCG Increased Survival of IVD Cells in Lethal Oxidative
Stress via PI3K/Protein Kinase B (Akt) Activation. To further
explore the mechanism underlying the action of EGCG, the
activity of the prosurvival PI3K/Akt pathway was studied.
As shown by immunoblotting, EGCG activated Akt under
oxidative stress conditions (Figure 6(a)). The biological rel-
evance of this finding was tested using the PI3K/Akt-specific
inhibitor LY294002 (LY). Depending on the type of stimulus,
Akt can activate various downstream signaling pathways
inducing proliferation, glucose metabolism, or survival. Akt
activator insulin, which stimulates cell proliferation, was used
as positive control to confirm the activity and specificity of LY.
As expected, insulin modestly increased the proliferation of
IVDcells (117.79±2.91%versus 100% in control), whereas the
addition of LY abolished this effect (108.16 ± 2.86%), hence
confirming the activity of LY for further PI3K/Akt pathway
tests (Supplementary Figure 1).
PI3K/Akt inhibition with LY did not significantly alter
the prosurvival effect of EGCG at 24 hours, as measured by
MTT assay (Figure 6(b)). However, at longer time points (48
hours), the difference in the metabolic activity between the
H
2
O
2
+ EGCG (80.01 ± 8.93%) and the H
2
O
2
+ EGCG +
LY (34.81 ± 4.69%) treatment group became significant
(Figure 6(c)), indicating that EGCG-based activation of the
PI3K/Akt pathway plays indeed an important role in the
survival of IVD cells under the oxidative stress.
4. Discussion
A stress-related decrease in the number of viable cells and
phenotypic changes of living cells are two major events in
the process of IVD degeneration that warrant therapeutic
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Figure 3: EGCG did not influence reactive oxygen species-induced loss of proliferative capacity. Senescence of IVD cells was induced with
50 𝜇MH
2
O
2
for 2 hours and proliferative capacity was evaluated on day 10 after stress. ((a)–(c)) Over a period of 10 days, the H
2
O
2
-treated
cells proliferated significantly less than the cells in control groups.Thenumber of cells in theH
2
O
2
andH
2
O
2
+ 10𝜇MEGCG treatment groups
did not significantly differ in either experimental setup (𝑛 = 5). ((d)–(f)) The activity of p53 and the expression of p21 were not significantly
affected by EGCG in either experimental setup (𝑛 = 5). ((g)–(i)) Metabolic activity in the H
2
O
2
and the H
2
O
2
+ EGCG treatment groups
did not significantly differ, indicating reduced proliferative capacity in all stress groups (𝑛 = 5). Asterisks indicate statistical significance at
𝑝 < 0.05 versus control group (ANOVA, Tukey post hoc).
targeting [32]. Oxidative stress-induced senescence and cell
death in vitro can represent mechanisms involved in human
disc aging in vivo [20, 21, 28]. We hypothesized that the nat-
ural polyphenol EGCG can inhibit oxidative stress-induced
senescence and/or cell death of IVD cells and we investigated
which mechanisms may be involved in its action.
In vitro as well as in vivo, EGCG can directly interact
with ROS or operate in an indirect manner by inhibiting ROS
generating enzymes or by chelating potentially prooxidant
metal ions [47]. Nevertheless, antioxidant activity is not the
only biological effect of EGCG. In fact, many of its health-
beneficial functions are independent of redox reactions.
Depending on the cell type, EGCG can interact with proteins
and phospholipids in the plasma membrane, regulate signal
transduction and gene expression andDNAmethylation, and
modulate mitochondrial function and autophagy [48].
Results of the radical scavenging assay confirmed the
previously reported antioxidant activity of 10𝜇M EGCG,
which can neutralize 32.89 ± 6.39% of 250𝜇M DPPH
radicals. Although higher concentrations of EGCG exhibited
better ROS trapping, they were not used in this study to avoid
possible unfavorable interactions with cell culture media
components. Dose-dependent oxidation of polyphenols and
subsequent ROS generation was reported as a common arti-
fact of in vitro cell culture [49, 50]. The thus induced toxicity
has no significance in vivo, because of the presence of plasma
antioxidants, but can interfere with research hypotheses via
increasing unspecific stress in cell culture. From this point of
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Figure 4: EGCG significantly inhibited reactive oxygen species-induced cell death. Cell death was induced by lethal concentration of H
2
O
2
(100𝜇M) applied for 24 hours. (a) 10 𝜇M EGCG significantly reversed the detrimental effects of H
2
O
2
on metabolic activity, measured by
MTT assay (𝑛 = 10). (b) 10𝜇MEGCG also significantly increased cell viability in oxidative stress, as measured by Propidium Iodide/Annexin
staining (𝑛 = 5). (c) Visualization of representative Propidium Iodide/Annexin V staining measured by flow cytometry. Asterisks indicate
statistical significance at 𝑝 < 0.05 (Student’s 𝑡-test).
view, 10𝜇MEGCGwas considered active, yet experimentally
safe.
We developed an in vitro model system of premature
senescence of IVD cells, induced by sublethal oxidative stress.
Due to the vastly heterogeneous nature of the senescence
phenotype, the use of various markers is required to precisely
identify senescence in a given cell population [14]. The
expression of certain markers, such as p21, can also increase
during in vitro cell culture as an artifact (Supplementary
Figure 1). Senescent cells commonly undergo cell cycle arrest,
start expressing SA 𝛽-gal, exhibit a senescence-associated
secretory phenotype (SASP), and activate p53-p21 and/or
p16-RB pathways [15, 27]. The morphology of senescent cells
can differ from their young counterparts: cells become bigger,
with prominent nucleoli and numerous cytoplasmic vacuoles
[51]. Sublethal doses of the widely used oxidative stress
inducer H
2
O
2
inhibited proliferation and activated the p53-
p21 pathway and SA𝛽-gal accumulation in IVD cells, proving
the suitability of the system to test potential antisenescence
compounds.
EGCG did not influence the progress of senescence
when applied during the recovery phase, suggesting no
interaction with poststress signaling. During recovery after
oxidative stress, cells can undergo several changes, one of
which can be the activation of gene expression towards
the senescence-associated secretory phenotype (SASP). The
SASP is mediated, for example, by the transcription factor
nuclear factor 𝜅B (NF-𝜅B) and many other redox-sensitive
transcription factors, which can induce the expression of
proinflammatory cytokines, proteases, and catabolic enzymes
[11, 15, 37].We have shown before that EGCG inhibited IL-1𝛽-
activated inflammatory responses in the IVD [38], implying
that EGCGmay act via similar mechanisms also in the ROS-
activated SASP. However, sublethal oxidative stress in our
settings did not increase the expression of inflammatory
markers (IL-6, IL-8) and catabolic enzymes (MMP1, MMP3,
and MMP13). Therefore, the effect of EGCG on SASP could
not be evaluated (Supplementary Figure 1). Previously, stress-
induced SASP was activated in IVD cells under different
culture conditions [27]; in our setup either longer time point
or higher ROS concentration may potentially be required.
As an antioxidant, 10 𝜇M EGCG inhibited accumulation
of SA 𝛽-gal but did not protect IVD cells from loss of
proliferative capacity, suggesting that the exogenous radicals
were not entirely neutralized. The increase in SA 𝛽-gal
expression/activity results from the need to compensate for
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Figure 5: EGCG inhibited the loss of mitochondrial membrane potential. Cell death was activated by lethal concentrations of H
2
O
2
(100𝜇M,
200 𝜇M) applied for 24 hours. (a) 10 𝜇M EGCG significantly inhibited mitochondrial membrane depolarization induced with 100 𝜇M
H
2
O
2
(𝑛 = 10). (b) 10𝜇M EGCG significantly inhibited mitochondrial membrane depolarization induced with 200 𝜇M H
2
O
2
(𝑛 = 10).
(c) Cellular morphology of the H
2
O
2
+ EGCG treatment group was different from the control group: signs of membrane blebbing and
nuclear condensation indicated that cell death was not completely inhibited (𝑛 = 5). (d) Ratio of red/green fluorescence showing the loss of
mitochondrial membrane potential in the H
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2
treatment groups. Asterisks indicate statistical significance at 𝑝 < 0.05 (ANOVA, Tukey post
hoc).
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Figure 6: PI3K/Akt is important for the protective function of EGCG under the lethal oxidative stress. Cell death was activated by 200𝜇M
H
2
O
2
. (a) After 15 minutes of cotreatment, 10𝜇MEGCG activated PI3K/Akt (𝑛 = 5). (b) After 24 hours, no significant difference inmetabolic
activity between the H
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the protective effects of EGCG, underlying the importance of the PI3K/Akt pathway in the survival of IVD cells (𝑛 = 5). Asterisks indicate
statistical significance at 𝑝 < 0.05 (ANOVA, Tukey post hoc).
the accumulation of damaged macromolecules and
organelles in lysosomes. As the expression of SA 𝛽-gal
is not required for senescence, we hypothesize that EGCG in
the antioxidant setup can ameliorate the increase in lysosome
dysfunction, rather than inhibiting a complex senescence
phenotype. In accordance with that, EGCG has been shown
to promote macroautophagy and lysosome recycling of
accumulated intracellular materials [52, 53]. Nevertheless,
the role of EGCG in enhancing cellular waste-disposal
mechanisms is still controversial and presumably cell-type
specific.
Since EGCG inhibited SA 𝛽-gal accumulation in the
antioxidant setup and not in the recovery setup, one could
expect similar responses when combining EGCG in both
stress and recovery phase. However, in the third setup,
SA 𝛽-gal assay showed only a trend towards the statistical
significance, possibly because a lower EGCG concentration
was applied in the stress phase, in order to avoid potential
toxic effects mentioned above [54].
As p16 is another important senescence marker, its
expressionwas initially tested in IVDcells treatedwith EGCG
in the antioxidant settings, on day 10 (𝑛 = 4). Because of
the fact that p16 expression in H
2
O
2
treatment groups was
detected only in 1 out of 4 donors, the experiments on p16
expression were not continued (Supplementary Figure 2).
In fact, the relative contributions of the p53-p21 and
p16-RB pathways to the senescence growth arrest may vary,
depending on the type and level of stress [55]. Moreover,
in different cell types, the transition of temporal to stable
cell cycle arrest can involve either an activation of p21 or
p16 or an activation of both [55]. Human IVD cells are
generally slowly proliferating and responding cell type in
whichROS canpossibly induce p16with delayed kinetics. p16,
if activated, subsequently provides a second barrier to stop
cell proliferation and plays a role in maintaining senescence,
rather than in its initiation, as suggested before [56, 57], which
may explain its low expression in our study.
To test whether EGCG can influence the expression of
p16, SAOS-2 cells, with constitutive expression of p16, were
treated with 10 𝜇M EGCG for 24 hours. This experiment
showed no influence of EGCG on the expression of p16 in
SAOS-2 (Supplementary Figure 2).
Lethal oxidative stress causes unrepairable damage on
mitochondrial membranes, leading to extensive ROS leakage
and quick activation of death signals [58] (Supplementary
Figure 3). Two independent viability assays revealed that
EGCG can significantly increase survival of IVD cells in
lethal oxidative stress. As a primary target of oxidative stress,
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mitochondria quickly lose their membrane integrity. We
demonstrated that EGCG can delay the onset of mitochon-
drial membrane depolarization, hence protecting mitochon-
dria from ROS leakage. Similar antioxidant effects of EGCG
were previously described, for example, in the mice liver
injury in vivomodel [59] or in rat retinal primary cells in vitro
[60].
As an exogenous oxidizing agent, H
2
O
2
produces
hydroxyl radicals, which can efficiently react with all cellular
components. On the other hand, damaged mitochondria
generate mainly superoxide, followed by lower amounts of
hydrogen peroxide and hydroxyl radicals [61, 62]. Therefore,
EGCG can affect mitochondrial ROS leakage by being a
good superoxide anion radical scavenger [62], but it may
neutralize other ROS species less efficiently (Supplementary
Figure 3). As previously reported, EGCG can also activate
superoxide dismutase expression, another mechanism to
counteract exclusively superoxide anion radicals and to pro-
tect mitochondria [63, 64].
Interestingly, EGCG activated PI3K/Akt under lethal
oxidative stress, an ability that was important for IVD cell
survival. We suggest that the reason why EGCG alone
did not activate PI3K/Akt pathway can be an absence of
the stress signal (H
2
O
2
). In nonstressed cells, the activity
of prosurvival pathways (such as PI3K/Akt) is negatively
regulated by their inhibitors (such as PTEN). In stressed
cells, the activity of intracellular kinase inhibitors can be
reduced [65] in order to facilitate activation of the prosurvival
kinases. However, the prosurvival kinases can fully function
only upon external activation [66]. Interestingly, it has been
shown that EGCG interactswith variousmembrane receptors
[48, 67]. We therefore hypothesize that EGCG-mediated
interaction upstream of Akt, in combination with stress-
mediated reduction in the activity of intracellular kinase
inhibitors, can lead to complete PI3K/Akt activation and
prosurvival effects in H
2
O
2
-treated cells.
Previously, Akt gene expression has been correlated with
increased disc cell proliferation in vitro [68] and lumbar disc
herniation in vivo [69]. More importantly, active PI3K/Akt
signaling enhanced prosurvival capacity of disc cells in vitro
[70] and antagonized disc degeneration in vivo [71]. The
PI3K/Akt pathway can therefore represent another attractive
therapeutic goal in disc degeneration, which can be targeted
by EGCG.
In this study, 2D cell culture was employed to ensure
applicability of cell analysis assays. Adherent in vitro system,
in contrast to 3D, reduced cell loss during analyses, which is
particularly important for stress experiments. The 2D system
also allowed quick and precise staining of organelles in living
cells. While results are very clear, it remains open whether
cells react similarly in their natural 3D environment. This
study is furthermore limited by the interdonor variability of
disc tissue biopsies, originating from differences in age and
degeneration grades [72]. Nevertheless, the use of primary
cells during first three passages represents a system more
close to human tissue than a stabilized cell line. The inter-
donor variability issue can be corrected by displaying results
relative to a control group, instead of using absolute numbers.
The main third limitation is that the effect of EGCG during
the recovery phase of senescence was tested in complete
media, which could possibly influence the activity of EGCG.
5. Conclusions
This study showed that EGCG can counteract oxidative
stress-induced changes of IVD cells in vitro via protec-
tion of the mitochondrial membrane from depolarization.
In oxidative stress, EGCG also activated PI3K/Akt as an
important prosurvival mechanism of IVD cells. As this
study did not provide direct evidence whether and how the
EGCG activated Akt andmitochondria protection are linked,
investigation of this coupling in IVD cells will be an objective
of future research.
Together with previously reported anti-inflammatory,
anticatabolic, and analgesic effects of EGCG, our findings can
be further used for the development of novel therapies target-
ing consequences of oxidative stress and neovascularization
in degenerative disc disease.
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